CStone Pharmaceuticals

DB:PH4 Stock Report

Market Cap: €943.0m

CStone Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:PH4 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Jun 26Buy€171,509Jianxin YangIndividual331,000€0.52
12 Jun 26Buy€100,745Jianxin YangIndividual200,000€0.50
12 Jun 26Buy€76,994Zhengguo HuIndividual150,000€0.51
12 Jun 26Buy€33,605Jianxin YangIndividual56,500€0.59
12 Jun 26Buy€50,262Wei LiIndividual100,000€0.50
11 Jun 26Buy€49,494Zhengguo HuIndividual100,000€0.49
11 Jun 26Buy€49,165Wei LiIndividual100,000€0.49
10 Jun 26Buy€68,207Jianxin YangIndividual145,000€0.47
10 Jun 26Buy€24,297Wei LiIndividual50,000€0.49
09 Jun 26Buy€93,925Jianxin YangIndividual200,000€0.47
08 Jun 26Buy€197,977Kenneth Walton HitchnerIndividual400,000€0.49
05 Jun 26Buy€105,112Jianxin YangIndividual200,000€0.53
03 Jun 26Buy€56,297Jianxin YangIndividual105,000€0.54
15 Apr 26Buy€8,154,821Morgan StanleyCompany7,959,183€1.02
15 Apr 26Buy€25,411,931Hillhouse Investment Management, Ltd.Company26,200,000€0.97
02 Apr 26Sell€2,570,334GIC Private LimitedCompany2,520,000€1.02
27 Mar 26Sell€11,169,005GIC Private LimitedCompany12,414,500€0.90
26 Mar 26Sell€2,363,574GIC Private LimitedCompany3,017,000€0.78
23 Jan 26Buy€88,643Jianxin YangIndividual148,500€0.60
22 Jan 26Buy€167,309Jianxin YangIndividual280,000€0.60
06 Jan 26Sell€2,832Jianxin YangIndividual4,817€0.59
23 Dec 25Buy€577,445GIC Private LimitedCompany904,500€0.64
04 Dec 25Buy€634,082Zhengguo HuIndividual1,000,000€0.63
14 Nov 25Buy€27,203Jianxin YangIndividual40,000€0.68
13 Nov 25Buy€70,382Jianxin YangIndividual117,500€0.60
12 Nov 25Buy€42,652Jianxin YangIndividual70,000€0.61
11 Nov 25Buy€59,308Jianxin YangIndividual100,000€0.59
03 Nov 25Buy€154,021Jianxin YangIndividual220,000€0.70
21 Oct 25Buy€238,050Jianxin YangIndividual300,000€0.79
20 Oct 25Buy€297,571Jianxin YangIndividual400,000€0.74
13 Oct 25Buy€1,747,699GIC Private LimitedCompany2,261,000€0.77
25 Sep 25Buy€128,768Jianxin YangIndividual150,000€0.86
09 Sep 25Sell€698,497Kenneth Walton HitchnerIndividual500,000€1.40
05 Sep 25Sell€292,412Zhengguo HuIndividual223,000€1.31
04 Sep 25Sell€300,748Zhengguo HuIndividual227,000€1.32
03 Sep 25Sell€52,260Jianxin YangIndividual39,375€1.33
20 Aug 25Sell€104,066,8786 Dimensions Capital LimitedCompany120,000,000€0.87
18 Aug 25Buy€69,624,764GIC Private LimitedCompany80,400,000€0.87
14 Jul 25Buy€5,670Jianxin YangIndividual10,000€0.57

Insider Trading Volume

Insider Buying: PH4 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PH4?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders27,564,1501.72%
Public Companies115,928,8037.25%
VC/PE Firms262,045,94416.4%
Institutions276,920,49417.3%
General Public915,749,94257.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.4%.


Top Shareholders

Top 25 shareholders own 42.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.9%
6 Dimensions Capital Limited
173,381,444€102.3m0%46.79%
7.25%
Pfizer Inc.
115,928,803€68.4m0%no data
5.55%
Hillhouse Investment Management, Ltd.
88,664,500€52.3m0%0.29%
4.76%
GIC Private Limited
76,040,500€44.9m-26.3%0.07%
4.03%
Morgan Stanley
64,381,558€38.0m-4.9%no data
2.5%
Boyu Capital Group Management Ltd.
40,017,948€23.6m0%2.32%
2.32%
Vanguard Capital Management, LLC
37,082,500€21.9m0.92%no data
1.34%
Jianxin Yang
21,437,683€12.6m8.57%no data
1.2%
BlackRock, Inc.
19,147,000€11.3m-2.69%no data
0.61%
Vanguard Fiduciary Trust Company
9,678,000€5.7m0%no data
0.34%
JP Morgan Asset Management
5,388,500€3.2m0%no data
0.21%
FMR LLC
3,334,500€2.0m0%no data
0.21%
E Fund Management Co., Ltd.
3,310,200€2.0m0%no data
0.19%
Invesco Capital Management LLC
3,075,403€1.8m0%no data
0.19%
Dacheng Fund Management Co., Ltd.
2,968,000€1.8m0%0.01%
0.17%
State Street Global Advisors, Inc.
2,729,500€1.6m-1.18%no data
0.16%
Principal Global Investors, LLC
2,589,500€1.5m0%no data
0.16%
Kenneth Walton Hitchner
2,513,481€1.5m18.9%no data
0.14%
Zhengguo Hu
2,283,495€1.3m17.1%no data
0.12%
Franklin Resources, Inc.
1,915,430€1.1m0%no data
0.094%
HSBC Global Asset Management (Hong Kong) Limited
1,495,000€882.1k0%0.02%
0.082%
Wei Li
1,312,491€774.4k174%no data
0.043%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
686,500€405.0k0%no data
0.039%
Geode Capital Management, LLC
624,500€368.4k-1.92%no data
0.036%
China Universal Asset Management Company Ltd.
575,100€339.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/12 21:10
End of Day Share Price 2026/07/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CStone Pharmaceuticals is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyi ChenGoldman Sachs
null nullGuoyuan Securities (HK) Ltd
Hanyang HuangIndustrial Securities Co. Ltd.